Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Vitamin A receptor" refers to two main types of proteins: STRA6, a cell-surface receptor that mediates retinol uptake, and nuclear retinoic acid receptors (RARs and RXRs), which regulate gene expression in response to retinoic acid. STRA6 facilitates the transport of retinol from retinol-binding protein (RBP) into cells, triggering intracellular signaling pathways. RARs and RXRs act as ligand-activated transcription factors that control the expression of genes involved in development, immunity, and metabolism. Dysregulation of these receptors is implicated in various diseases, including developmental disorders and cancer.
STRA6: Mediates cellular retinol uptake and activates intracellular signaling cascades (JAK/STAT). RAR/RXR: Bind to retinoic acid response elements (RAREs) in DNA, regulating transcription of target genes.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vitamin A Receptor.